IQVIA has rolled out a trial technology platform it claims will provide research sites with a “dashboard” for key systems and tasks.
The platform – called “One Home” – is being marketed as a way of helping clinical research sites working on multiple studies to reduce “technology overload” by integrating the software and systems they use into a single platform.
IQVIA sited manging the “scores of usernames and passwords” required by the various systems as an example.
Bernd Haas, senior vice president of digital production and solutions, said “With site capacity becoming a real challenge for the industry, we believe it is our role and responsibility to deliver a solution that brings industry stakeholders together and relieves the burden on research sites.”
This was echoed by Richard Staub, president, IQVIA Research & Development Solutions who added “Rather than competing with individual products and platforms, it enhances sites’ productivity by aggregating clinical trial systems, and I believe that it will be incredibly valuable to the clinical research space and in the studies we run.”
IQVIA – which developed the system with input from 100 drug research site personnel – has launched it at its so-called Prime Sites, which are a network of clinical trial centres across he globe.
The US headquartered services and information firm has also engaged with dozens of clinical technology vendors – such as Medidata – as well as pharmaceutical companies to better understand industry needs.
And industry needs are complex according to Sharlene Carnegie, senior vice president, Platform, Medidata said “There is a vast and disparate landscape of technology solutions that, as a whole, is impacting site users.
The launch comes a few weeks after IQVIA premiered a participant payment system designed to help research sites automate the remuneration of people who take part in drug studies.
DepositPhotos/everythingposs